Home/Filings/4/0001104659-24-074024
4//SEC Filing

Bastone Bronwen 4

Accession 0001104659-24-074024

CIK 0001868912other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:38 PM ET

Size

7.1 KB

Accession

0001104659-24-074024

Insider Transaction Report

Form 4
Period: 2024-06-18
Bastone Bronwen
Chief People Officer
Transactions
  • Sale

    Class A Common Stock

    2024-06-20$8.11/sh18,241$147,935198,913 total
  • Sale

    Class A Common Stock

    2024-06-18$8.17/sh10,539$86,104217,154 total
Footnotes (3)
  • [F1]Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.06 to $8.28. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
  • [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.02 to $8.17. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Issuer

Enfusion, Inc.

CIK 0001868912

Entity typeother

Related Parties

1
  • filerCIK 0001927636

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:38 PM ET
Size
7.1 KB